Background and Aims: The intestinal microbiota is a key antigenic driver in Crohn's disease [CD]. We aimed to identify changes in the gut microbiome associated with, and predictive of, disease recurrence and remission. Methods: A total of 141 mucosal biopsy samples from 34 CD patients were obtained at surgical resection and at colonoscopy 6 and/or 18 months postoperatively; 28 control samples were obtained: 12 from healthy patients [healthy controls] and 16 from hemicolectomy patients [surgical controls]. Bacterial 16S ribosomal profiling was performed using the Illumina MiSeq platform. Results: CD was associated with reduced alpha diversity when compared with healthy controls but not surgical controls [p < 0.001 and p = 0.666, respectively]. Beta diversity [composition] 
Introduction
The pathogenesis of Crohn's disease [CD] involves interactions between the host genome, gastrointestinal [GI] microbiota, and mucosal immune system. Genetic alterations associated with the development of CD appear to lead to perturbation of the delicate relationship between the microbiota and the host, with a consequent dysregulated immune response and intestinal inflammation. 1 The microbiome plays a critical role in this process. 2, 3 Patterns of change in the GI microbiota have begun to emerge in CD patients, including reduction in within-sample biodiversity [α diversity] and decreased representation of several taxa including Faecalibacterium, and an increase in the Gammaproteobacteria. 3 Other specific taxonomic shifts have been reported in CD 2 ; however, interpretation of these changes across different studies is difficult because of heterogeneity of study populations and methodology and differences in sampling site.
Surgery is required in a majority of CD patients. Following the resection of all macroscopic disease, endoscopically identifiable lesions are apparent within weeks to months, 4 , most commonly in the neo-terminal ileum and at the surgical anastomosis. Recurrence occurs more commonly in smokers. 5 The neo-terminal ileum is recolonised by the microbiota postoperatively. 6 CD -specific microbe profiles have identified the ileum as the primary inductive site for all forms of disease. 7 The postoperative setting, with interrogation of the GI microbial community at the neo-terminal ileum, is an ideal clinical environment in which to explore the changes in the GI microbiome with respect to the presence or absence of disease recurrence.
Limited studies have examined the microbial communities postoperatively in patients with CD. 6, 8, 9, 10 Sokol et al. 8 found that a lower proportion of F. prausnitzii in resected ileal Crohn's mucosa was associated with increased risk of endoscopic recurrence at 6 months [p = 0.03], suggesting that there may be a microbial signature, detectable at the time of resection, that is associated with the risk of recurrence postoperatively. These findings were replicated in smaller studies from Dey et al. 9 and De Cruz et al. 10 Most recently Mondot et al., 11 in a study of 20 patients with Crohn's disease, described changes in the gut mucosal microbiota after ileocaecal resection. 'Bacterial dysbiosis' was associated with postoperative recurrence.
We performed a study in a well-characterised cohort of CD patients, followed from the time of surgery to 18 months postoperatively, to identify 16S microbiota profiles associated with postoperative CD disease recurrence. Here we report our next-generation sequencing analysis on 141 mucosal biopsy samples from 34 CD patients. The combination of our large sample size, longitudinal observations, concurrent sampling from different sites [ileum and anastomosis], and the use of unbiased high-throughput sequencing, are key strengths of this study.
Methods

Subjects and ethics approval
The present study was undertaken in parallel with a clinical study examining the management of Crohn's disease postoperatively (the Postoperative Crohn's Endoscopic Recurrence ['POCER'] study; Clinical Trial Registration: NCT00989560).
The clinical POCER study was a prospective, randomised, controlled trial which aimed to assess the value of postoperative endoscopic assessment and treatment step-up for early mucosal recurrence. 12 Patients were stratified according to risk of recurrence. Smokers, patients with perforating disease, or patients with one or more previous resection were classified as 'high-risk'; all others were 'low-risk'.
Patients underwent resection of all macroscopic disease and then received 3 months of metronidazole. High-risk patients also received daily azathioprine [ Patients with a family history of bowel cancer, with an intact colon and normal colonoscopy, were recruited as healthy controls. Surgical controls included patients undergoing surveillance colonoscopy who had previously undergone right hemi-colectomy for colonic cancer and were in remission.
Mucosal samples from the CD patients were collected at the time of resection and at colonoscopy 6 and/or 18 months postoperatively, and in controls at the time of screening colonoscopy. Faecal samples were taken at 6 and 18 months postoperatively.
No patient or control received antibiotics or probiotics in the month before the operation or colonoscopy. Patients had intestinal cleansing with polyethylene glycol on the day before surgery, and the same preparation was used in all patients and controls before colonoscopy. Controls were not matched for age, gender, or body mass index (BMI). All patients provided written informed consent.
Tissue collection and DNA extraction methods
In the CD patients, 5-10 mg tissue samples were obtained from the resection specimen at the affected ileum. At 6-and 18-month colonoscopy, tissue samples [each 5-10 mg] were collected from the anastomosis and neo-terminal ileum. In healthy controls, biopsies were taken from the ileum and in surgical controls, biopsies were taken from the anastomosis and neo-terminal ileum. Standard endoscopic forceps were used and tissue was placed in a sterile tube containing 1 ml RNA later [Ambion] , held at 4°C overnight to allow full tissue penetration, then stored at -80°C. Individual tissue samples were subsequently thawed and homogenised using mechanical disruption in lysis buffer as described previously 13, 14 and the DNA extracted from the homogenate using the QIAGEN AllPrep Mini Kit as per the manufacturer's instructions. Comparisons within CD patients and between CD and controls were made with respect to changes identified in the ileal mucosa. Unless otherwise stated, results reflect findings from the ileal mucosa.
Faecal collection
Faecal samples were collected for measurement of faecal calprotectin [FC] . Patients were instructed to collect stool samples no more than 3 days before the study visit, or if colonoscopy was to be performed, 3 days before colonoscopy. Samples were stored at -20 degrees Celsius in the patient's home freezer, transported on ice, and stored at -80 degrees Celsius at study centres until conclusion of the study. All samples were then analysed simultaneously in a central laboratory.
FC was measured by a quantitative enzyme immunoassay [fCAL TM , Bühlmann, Schonenbuch, Switzerland] as per manufacturer's instructions. We have previously shown that an FC > 100 µg/g is sensitive for the diagnosis of CD endoscopic recurrence postoperatively 15 and selected this cut-off for analysis.
16S rRNA gene sequencing
The bacterial 16S rRNA variable region 2 was amplified by polymerase chain reaction [PCR] with Illumina index/adaptors using the Expand High Fidelity PCR kit [Roche] . PCR products were purified using the Qiagen DNA extraction kit [Qiagen] and quantified using a Nanodrop before Illumina MiSeq sequencing performed at the Australia Genome Research Facility [AGRF], using 250-cycle chemistry enabling 250bp sequencing from both ends.
Bioinformatics and statistical analyses
The MiSeq-generated overlapping paired-end sequence reads were first trimmed to 200 bp using FASTX-Toolkit version 0.0.14 [http:// hannonlab.cshl.edu/fastx_toolkit/], and then merged using Flash version 1.2.7.
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The merged sequences were subsequently processed using QIIME v1.8. 17 Sequences were quality-filtered as follows: ≤ 3 low-quality bp [Phred quality score < 3] allowed before trimming, ≥ 189 consecutive high-quality bp with no uncalled bases [Ns] . 18 Chimeras were removed using the UCHIME reference-based method. 19 A total of 2 464 848 sequences were filtered out [7%], leaving 35 034 316 for analysis. Quality-filtered sequences were assigned to operational taxonomic units [OTUs] using the subsampled open reference method 20 with the Greengenes 97% OTU reference set, version 13_5. 21 Briefly, the input sequences were pre-filtered against the reference set at a low percentage identity of 60% to remove sequences that are likely sequencing errors. Next, the closed reference OTU picking was applied on the filtered sequences [closed reference method uses UCLUST 22 to search each read against the database, and assigns the read to an OTU based on the best hit at ≥ 97% sequence identity]. All sequences that did not match the reference at the closed reference step were then de novo clustered at 97% similarity. OTUs with support from only a single read were discarded. Taxonomy was assigned using the RDP classifier 23 with the Greengenes 97% OTU reference set. Alpha diversity measures [number of OTUs, Shannon's Diversity Index, and Chao Diversity Index] were evaluated on 10 independent rarefaction runs per sample. Beta diversity was calculated using the unweighted UniFrac metric. 24 All subsequent statistical analyses were performed using R, unless stated otherwise. Statistical analyses of alpha diversity were performed using Wilcoxon rank sum test where appropriate. For taxonomic analysis, the relative abundance of each taxon was calculated and summarised at phylum, family, and genus level. Statistical analyses of taxonomic differences were performed using Wilcoxon rank sum test. We acknowledge that performing OTU association analyses does incur a substantial multiple testing burden which we have addressed using a false discovery rate [FDR] adjustment. Statistical significance was defined as a p-value of < 0.05. When an FDR-adjusted p-value was < 0.05, results are referred to in the manuscript as being 'significant following FDR adjustment < 0.05'; otherwise, 'significance' implies a non-FDR adjusted p < 0.05. Regression analysis for endoscopic recurrence against smoking was performed using a generalised estimating equation [GEE] with unstructured correlation and robust standard errors to take into account multiple samples from the same patient. Principal coordinates analysis was performed on the unweighted UniFrac distance matrix. Statistical significance of differences in community composition were assessed using the Adonis method, a nonparametric multivariate analysis of variance [ANOVA] using QIIME v1.8 17 . 25 When Adonis was performed between specific groups, correction for multiple testing was performed using FDR adjustment.
Endoscopic visual assessment
At ileo-colonoscopy, mucosal recurrence at the anastomosis and neoterminal ileum was assessed according to the 4 Photographs of the anastomosis and neo-terminal ileum were also scored by two investigators [PDC and MAK], blinded to both the endoscopist's score and the patient's identity and treatment. A final consensus score was determined by the two blinded assessors. [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] ; all patients were free of colonic cancer at the time of follow-up colonoscopy. Demographic details for CD patients and controls are shown in Table 1 .
Results
The postoperative Crohn's disease cohort
Of the 34 CD patients, 27 underwent colonoscopy at 6 months; of these, 17 were in endoscopic remission and 10 had disease recurrence. At 18 months, 27 patients underwent colonoscopy, of whom 13 were in endoscopic remission and 14 had disease recurrence [ Figure 1 ].
An average of > 190 000 [range 75020-465400] taxonomyassigned 16S sequences per sample were obtained using the Illumina MiSeq platform. Read counts were normalised by randomly subsampling each sample to 75 000 reads [rarefaction] before diversity calculations. Taxa were classified as being detected if any reads, regardless of number, were detected. Any taxa that was present in < 10% of all samples were excluded.
p-Value determination was performed both with and without false discovery rate [FDR] adjustment. Unless otherwise stated, p-values reported below are without FDR adjustment.
Alpha diversity
The alpha diversity analyses are summarised in Table 2 There were no statistically significant differences in alpha diversity in CD patients when ileal biopsies from baseline where compared with postoperative ileal samples at 6 and 18 months. A difference at baseline could not be detected between those who remained in endoscopic remission at 6 or 18 months versus those who went on to develop endoscopic recurrence. There were no statistically significant differences in alpha diversity between those in endoscopic remission versus recurrence [Rutgeerts ≥ i2] at 6 months or 18 months, nor between those with mucosal normality [Rutgeerts i0 ] versus severe recurrence [Rutgeerts i3 and i4]. Smokers did not differ significantly in alpha diversity compared with non-smokers when ileal samples from CD patients from all time points were compared. As a separate measure of recurrence and remission, FC > 100 μg/g was not associated with a significant change in alpha diversity when compared with FC ≤ 100 μg/g.
Within the CD cohort, there was no statistically significant difference in alpha diversity between samples taken from the neo-terminal ileum when compared with the anastomosis. Figure 2 and Table 2 show the results of these analyses with the values shown for Shannon Diversity Index. Similar results were obtained using number of OTUs and Chao Diversity Index. In consideration of a postoperative ileal resection and ileocolonic anastomosis, CD patients, at both 6 and 18 months postoperatively, differed significantly from surgical controls [ p = 0.022 and p = 0.027, respectively] Figure 3A . Table 1 . Patient demographic data, disease phenotype, postoperative medical therapy, and 6-and 18-month postoperative endoscopic findings.
Demographics
Cases n = 34 Controls n = 20
Normal n = 12 Surgical n = 8 Figure 3B .
Paired samples from the ileum and the anastomosis taken from the same patient at one time point were significantly more similar than samples taken from the same site in different patients at the same time point (mean unweighted Unifrac 0.39 versus 0.63, respectively, p < 0.001 [p = 0.001 following FDR adjustment]), Figure 3C and D. Metronidazole 3 months n = 1
Step up Continue Thiopurine Add fortnightly Adalimumab Table 3 ].
3.4.2.
Crohn's disease: bacteria at resection and subsequent recurrence At baseline, significant differences in specific taxa were observed between patients who, at 6 months postoperatively, remained in endoscopic remission compared with those who went on to develop endoscopic recurrence. These included significant increases in the Firmicutes phylum [p = 0.018], the Bacteroidaceae and Pasteurellaceae families [p = 0.046 and p = 0.020, respectively] and the Bacteroides genus [p = 0.046] in patients with subsequent remission when compared with those with subsequent recurrence. These baseline differences were not observed between patients who remained in remission or had recurrence at 18 months postoperatively. The abundance of Faecalibacterium or the presence or absence of Proteus at the time of resection were not predictive of later endoscopic remission or recurrence at 6 or 18 months.
Postoperative Crohn's disease over time and endoscopic recurrence
Bacterial composition in CD changed over time, with many taxonomic changes significant following FDR adjustment [ 
Crohn's disease: effect of smoking
Active smoking in this cohort was associated with endoscopic recurrence (OR 3.3 [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] . p = 0.049], independent of the presence of Faecalibacterium and Proteus. Active smoking was associated with significant differences in several taxa compared with non-smokers at 6 and 18 months [ Table 5 ]. At 6 months, Proteus was increased [p = 0.037] in smokers when compared with non-smokers. 
Crohn's disease: faecal calprotectin
Proteus, Faecalibacterium, smoking and endoscopic recurrence
Of the 24 patients with recurrence at either 6 and/or 18 months, 20 were associated with low Faecalibacterium abundance or the presence of Proteus [ Figure 4 ].
A microbial profile at 6 or 18 months comprising a high abundance of Faecalibacterium and absent Proteus had a sensitivity for endoscopic remission of 84%, specificity of 69%, positive predictive value [PPV] of 70%, and negative predictive value [NPV] of 83%. 
Taxonomic identification at a species level
In this study cohort, 867 OTUs were identified as Faecalibacterium. Of these, 857 [99%] were identified as F. prausnitzii at species level.
Four distinct OTUs [Greengenes OTUs 4440497, 814112, 560629, and a de novo OTU] were identified as belonging to the Proteus genus, but these could not be identified at species level. Of these, OTU 814112 was most abundant [65% of all reads] and present, at least in part, in 19 of the 21 samples where Proteus was detected. When the representative full-length 16S sequence for this OTU was examined and compared with the National Center for Biotechnology Information [NCBI] BLAST reference database, it was most closely matched to the species P. mirabilis [query cover 100%, E value 0.0, identity 95%]. OTU 560629 was also found to be a best match for P. mirabilis [query cover 100%, E value 0.0, identity 98%].
Discussion
Crohn's disease-specific host and microbe profiles have identified the ileum as the primary inductive site for all disease forms. 7 Postoperative studies of the microbial community at the neo-terminal ileum therefore have the potential to identify organisms of causative importance.
This study has identified significant differences in the ileal microbial profiles in patients with CD compared with healthy controls, in line with previous studies. 2, 3 Additional taxa were identified as being associated with CD [ Table 3 ]. This study has employed highthroughput Illumina sequencing and the potential identification of organisms with low abundance.
No significant differences in alpha diversity were observed between patients who went on to develop recurrence compared with those who stayed in remission or between those with postoperative recurrence compared with remission, but numbers were relatively small and analysis may have been underpowered.
Three key findings have emerged from this study. First, low abundance of Faecalibacterium prausnitzii and the presence of Proteus in the postoperative ileal mucosa are significantly associated with postoperative recurrence, independent of smoking. Second, the progression of recurrent disease, from low-grade mucosal inflammation [identified by an elevated FC] to severe The appendix may play a role in preserving and protecting beneficial or commensal microorganisms in the gut. 26 In this study, surgical controls were patients who had previously undergone right-hemicolectomy for colon cancer. A change in the microbiota of colon cancer patients has been described, 27, 28 including an over-representation of Firmictutes, Fusobacteria and phylotypes closely related to Bacteroides, and a reduction in the abundance of the Proteobacteria, Faecalibacterium and Roseburia, compared with healthy controls. 28, 29 This should be considered when interpreting our results. Similar to previous studies, we have shown that the abundance of F. prausnitzii is associated with endoscopic remission postoperatively. 8, 9 In our study, Proteus spp. were detected in 12 patients [41%] with CD. Proteus was not found in either healthy or surgical controls. When detected at 6 months postoperatively in the ileum, it was strongly associated with recurrence, independent of smoking, increasing the risk of recurrence 13-fold.
Faecalibacterium is a common gut bacterial genus, To test recurrence against low Faecalibacterium abundance, a cut-off value of zero reads could not therefore be used. Setting the cut-off at either 0.01% or 0.1% yielded the same results. For Proteus genus, however, abundance was very low and in many samples not detected at all. In samples with detectable Proteus, the median number of reads from each sample when present was low at 35 (interquartile range [IQR] 782). For this reason, a cut-off of any detectable Proteus was chosen.
Proteus spp. is a member of the Enterobacteriaceae family and can be found in the normal gastrointestinal flora. Although not traditionally thought to be pathogenic in the gastrointestinal tract, Proteus spp. are commonly associated with complicated urinary tract infections. 30 The Enterobacteriaceae family have been found to be consistently increased in the intestinal tissue and faeces of patients with CD when compared with healthy controls, 7, 31 although few studies have examined the presence or role of Proteus in inflammatory bowel disease. Garrett et al. 32 found that the presence of Proteus mirabilis in T-bet -/-Reg -/-ulcerative colitis [TRUC] mice can elicit colitis in specific-pathogen free mice but not in wild-type mice. In a study of 25 paediatric patients with inflammatory bowel disease, Proteus was found in 16.7% of CD patients but was not found in patients with ulcerative colitis, indeterminate colitis, or healthy controls. 33 Mondot et al. 11 have recently shown a relationship between the presence of Proteus mirabilis, when detected in the faeces of patients with Crohn's disease undergoing ileocaecal resection, and future endoscopic recurrence. These data concord with our findings of the association between Proteus and disease recurrence, in an examination of the mucosal microbiota in a large postoperative cohort of patients with Crohn's disease.
In this study, 88% [21/24] was associated significantly with an FC > 100 µg/g in this study. Pseudomonas spp. have been found to be more prevalent in the ileal mucosa of children with CD compared with healthy controls and has been implicated in the pathogenesis of CD. 14 In the current study, although Pseudomonas was associated with an elevated FC, it was not more abundant in patients with endoscopic recurrence. In contrast, the detection of Proteus and a low abundance of F. prausnitzii were associated with endoscopic recurrence, but not increased FC. Only a low abundance of F. prausnitzii was associated with severe recurrence and this was observed, along with a significant reduction in beta diversity and other taxonomic differences, only at 18 months postoperatively. These findings suggest that there is an evolution of different stages of recurrent inflammation. These stages may be associated with different microbial profiles.
This study has explored the inter-relationship between different gut bacterial populations and CD recurrence. We have also explored the possible additive effect of the environmental factor, smoking, known to have the greatest effect on the risk of disease recurrence after surgery. Modelling based on data from these real observations may have an important role in identifying a patient's risk of recurrent disease. Further experimental work is also needed to explore the nature of the inter-bacterial relationship. At this stage, a causative relationship has not been established. The diagnostic model proposed in this study requires validation in an independent cohort.
All CD patients in this study were exposed to metronidazole therapy for the first 3 months postoperatively, and some patients received a thiopurine or adalimumab. The detailed assessment of the postoperative ileal microbiome with respect to drug therapy was limited by the heterogeneous treatment regimens used in the clinical study and the relatively small numbers in each drug regimen cohort. No CD patient and no control patient received antibiotics in the 3 months preceding collection of tissue. Of the five patients with reported postoperative complications, three had postoperative ileus, one had an upper gastrointestinal bleed, and one had chest sepsis. The patient with chest sepsis was the only patient to require additional antibiotics. These were given immediately after surgery, but not at the time of later biopsies. Although CD patients received antibiotics and immune-suppressing drugs, the key analysis relates to the relationship between recurrent inflammation [despite previous antibiotics] and the microbiota.
Certain demographic aspects of the different studied patient populations could not be standardised. These included the difference in age, gender, and BMI between controls and CD patients. In addition, it was not possible to standardise diet or account for the wide range in dietary patterns of patients.
In summary, ileocaecal resection may be responsible for some of the bacterial differences observed in patients following intestinal resection in Crohn's disease. Microbial factors, such as the presence of F. prausnitzii, Proteus spp., and smoking may influence postoperative Crohn's disease recurrence through independent mechanisms. Proteus spp., when detected postoperatively in the neo-terminal ileum even in very low abundance, may play a role in the development of early postoperative recurrence. Quantitative PCR studies of tissue and faeces from our postoperative cohort are under way, which will focus on further defining the presence of Proteus spp. Functional studies, including 16s rRNA metagenomic surveys, are also required to elucidate the pathophysiological changes associated with these microbial changes.
